Literature DB >> 3872161

A case of T-cell chronic lymphocytic leukemia with an unusual phenotype and central nervous system involvement.

K Oshimi, M Akahoshi, N Hagiwara, M Tanaka, H Mizoguchi.   

Abstract

A case of T-cell chronic lymphocytic leukemia is reported. The leukemic cells had the morphologic features of medium-sized, mature-looking lymphocytes, and had an affinity for the central nervous system. Cytochemically, they were positive for alpha-naphthyl acetate esterase and acid phosphatase. They formed E-rosettes (E+) and reacted with OKT11 but not with OKT3/Leu-4, OKT4/Leu-3, OKT8/Leu-2, or OKM1, and did not possess IgG-Fc receptors (Fc gamma R). Functionally, they did not respond to phytohemagglutinin or concanavalin A, were not natural killer cells or antibody-dependent as well as alloantigen-reactive killer cells. Furthermore, they did not possess a helper or suppressor T-cell function for immunoglobulin synthesis. Results of immunologic studies suggest that the leukemic cells were derived from a normal counterpart of a lymphocyte subset present as a minor component of the peripheral blood, namely an E+, OKT3-, OKM1-, Fc gamma R- subset, the function of which is not yet identified.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872161     DOI: 10.1002/1097-0142(19850501)55:9<1937::aid-cncr2820550918>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Leptomeningeal Carcinomatosis in Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature.

Authors:  Alipi V Naydenov; Lynne P Taylor
Journal:  Oncologist       Date:  2019-03-06

2.  Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review.

Authors:  Alan A Moazzam; Jan Drappatz; Ryan Y Kim; Santosh Kesari
Journal:  J Neurooncol       Date:  2011-07-17       Impact factor: 4.130

3.  Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab.

Authors:  Naoko Watanabe; Takayuki Takahashi; Naoshi Sugimoto; Yasuhiro Tanaka; Masayuki Kurata; Akiko Matsushita; Akinori Maeda; Kenichi Nagai; Kohji Nasu
Journal:  Int J Clin Oncol       Date:  2005-10       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.